Insider Trading? Huge Bet Made Shortly Before STAT News Report Touting Gilead's Remdesivir Results

1/6 Been spending a lot of time after the close trying to figure out some inconsistencies with this Remdesivir news. With that said let me be clear, this is just what I found and my personal opinions only, it is not meant to be a conspiracy theory but do wanna share it anyway pic.twitter.com/KImaMgXlvD

— Tian (@RealTianZeng) April 17, 2020

3/6 BUT, it was weird this reporter put out this incomplete study at the close when there's no liquidity, before GILD would release the official stats anyway in about 7 days - the information was retrieved from a video in which the doctor was speaking to other faculty at UChicago

— Tian (@RealTianZeng) April 17, 2020

5/6 so I looked up the reporter Adam Fuerstein, and he has been previously accused of some "stuff", I don't see it ever was proven but you can judge for yourself out of the Washington Post back in 2014, the letter to SEC is no longer available on the webhttps://t.co/2oAoVKh0OS

— Tian (@RealTianZeng) April 17, 2020

6/6 but imagine you the Biotech Hedge Fund guy who bought up GILD shares and/or call options and then have one of your buddies put it out on an article (on a medical website to get more legitimacy) or to tweet it out to a large following, especially during time of sensitivity

— Tian (@RealTianZeng) April 17, 2020

34k Open Interest, 7.5k traded today - the friggin thing expires TOMORROW, no one buys this many the day before unless they know something pic.twitter.com/xM75D6wvE6

— Tian (@RealTianZeng) April 17, 2020

April 17th $80 call, expires tomorrow, article comes out the day before...

— Tian (@RealTianZeng) April 17, 2020

Interesting. Those options were bought today for an average of $15 a piece and with after hours price of $89.10 on Gilead stock means they are worth $910 each (assuming stocks opens at that tomorrow) 7,500 contracts. Huge gain

— Adam Carroll (@ACIndyColt) April 17, 2020

Turn $7k into $6.5 million in 24 hours, beats working for a living.

— Paul DiChristina (@PMDiChristina) April 17, 2020

A congressman on Friday called for the Securities and Exchange Commission to investigate the leak of a video showing physicians at the University of Chicago speaking enthusiastically about an experimental drug to treat Covid-19.

Texas Democrat Rep. Lloyd Doggett, chair of the House Ways and Means Health Subcommittee, said the leak was "so significant" at a time when the world is "so desperate to find a cure."

[...] The video was leaked to STAT News, a health news website, which published it Thursday afternoon. The story was picked up widely by other news outlets, including CNN, and Gilead stock soared 12%.

Doggett, an attorney, noted that "providing information that's designed to impact the stock market is not something that is permitted under federal securities law."

He said it's not clear where the leak came from. "That's why we need a thorough SEC investigation," he said.

@adamfeuerstein is the author of the Stat article about the early peek on the Gilead trial and he is the best there is and a great friend. So i like what i read

— Jim Cramer (@jimcramer) April 16, 2020

Thank you, Jim.

— Adam Feuerstein (@adamfeuerstein) April 16, 2020

Adam is about to finally get busted cant believe it took this long. https://t.co/t9GG8MDMiz

— I'm an Iconoclast (@DaPerl) April 19, 2020